Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

32 results
Display

Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol

Suh HC, Kim DK, Kang SH, Seo KM, Kim HS, Lee JY, Lee SY, Yoo KY

OBJECTIVE: To assess the clinical outcome of chemical synovectomy with rifampicin in hemophilic arthropathy by using the World Federation of Hemophilia (WFH) scoring system and plain radiograph. METHODS: We performed rifampicin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System

Wang HY, Uh Y, Kim S, Cho E, Lee JS, Lee H

BACKGROUND: The increasing prevalence of drug-resistant tuberculosis (TB) infection represents a global public health emergency. We evaluated the usefulness of a newly developed multiplexed, bead-based bioassay (Quantamatrix Multiplexed Assay Platform...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rifampicin Alleviates Atopic Dermatitis-Like Response in vivo and in vitro

Kim SH, Lee KM, Lee GS, Seong JW, Kang TJ

Atopic dermatitis (AD) is a common inflammatory skin disorder mediated by inflammatory cells, such as macrophages and mast cells. Rifampicin is mainly used for the treatment of tuberculosis. Recently, it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rifampicin-Induced Minimal Change Disease Is Improved after Cessation of Rifampicin without Steroid Therapy

Park DH, Lee SA, Jeong HJ, Yoo TH, Kang SW, Oh HJ

There are several reports to demonstrate that rifampicin, a major anti-tuberculosis agent, is associated with some adverse renal effects, with a few cases of rifampicin-induced minimal change disease (MCD). In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach

Kumar S, Jena L

The disease tuberculosis, caused by Mycobacterium tuberculosis (MTB), remains a major cause of morbidity and mortality in developing countries. The evolution of drug-resistant tuberculosis causes a foremost threat to global...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of High dose Colchicine with No Efficacy in a Patient with Chronic Kidney Disease Taking Rifampicin

Koo HS, Kim S, Chin HJ

A 54-year-old male on chronic hemodialysis, who was taking rifampicin for tuberculous lymphadenitis, was admitted for an acute gout attack. After administrating 3.6 mg of colchicine for 2 days, symptoms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tracing the Variation in Physiological Response to Rifampicin Across the Microbial Spectrum

Dey A, Chatterji

Rifampicin is an acknowledged inhibitor of bacterial RNA polymerase. We observed that there exists a substantial variation in the basal-level tolerance to rifampicin across microbial species. A number of mechanisms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rifampicin Inhibits the LPS-induced Expression of Toll-like Receptor 2 via the Suppression of NF-kappaB DNA-binding Activity in RAW 264.7 Cells

Kim SK, Kim YM, Yeum CE, Jin SH, Chae GT, Lee SB

Rifampicin is a macrocyclic antibiotic which is used extensively for treatment against Mycobacterium tuberculosis and other mycobacterial infections. Recently, a number of studies have focused on the immune-regulatory effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rifampicin-Induced Severe Hyperkalemia Requiring Hemodialysis in a Patient with Addison's Disease

Kim HG, Yoon YS, Kim HH, Kim YS, Kim BS, Yoon SA, Kim YO

  • KMID: 2253205
  • Korean J Nephrol.
  • 2009 Jan;28(1):44-48.
Rifampicin, a potent inducer of hepatic microsomal enzymes, increases metabolism of steroid hormone. Therefore, concurrent treatment of rifampicin and steroid may lead to decreased bioavailability and increased requirement of steroid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pseudomembranous Colitis Associated with Rifampicin Therapy in a Patient with Rectal Cancer and Gastrointestinal Tuberculosis

Choi YJ, Kim HG, Choi YA, Joo WC, Son DW, Kim CH, Shin YW, Kim YS

  • KMID: 783128
  • Korean J Gastroenterol.
  • 2009 Jan;53(1):53-56.
Pseudomembranous colitis (PMC) is known to be associated with the administration of antibiotics which alter normal gastrointestinal flora and allow overgrowth of Clostridium difficile. Most cases of rifampicin-induced PMC are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of rifampicin-induced interstitial pneumonitis

Jeong JI, Jung BH, Kim MH, Park YJ, Hea TY, Rhui DS, Kang GH

  • KMID: 2256074
  • Korean J Med.
  • 2008 Nov;75(5):592-596.
Rifampicin is a powerful agent for the treatment of pulmonary tuberculosis. However, it may induce several adverse effects, including rare cases of lung toxicity. Here, we report a case of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Suppressive Effect of Rifampicin in Animal Model of Hemophilic Synovitis

Lee SH, Lee YA, Park EK, Kim KS, Cho YJ, Han JS, Yoo MC, Yang HI

OBJECTIVE: Hemophilic arthropathy, which results from recurrent intra-articular bleeding, is a proliferative synovitis, but the sequence of pathogenic events in hemophilic synovitis (HS) is not known in detail. To investigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatotoxicity of Rifampicin and Pyrazinamide Treatment Excluding Isoniazid

Choi IS, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS

  • KMID: 2318776
  • Tuberc Respir Dis.
  • 2006 Jan;60(1):38-43.
BACKGROUND: Even though two-month rifampicin (RMP, R) and pyrazinamide (PZA, P) treatment has some advantages over isoniazid (INH, H) treatment for latent tuberculosis infection (LTBI), it was withdrawn from the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rifampicin Induced Pseudomembranous Colitis in Elderly Patient

Bong JD, Boo GB, Sim DS, Park HO, Lee TW, Koh KS, Chung JJ

  • KMID: 2338382
  • J Korean Geriatr Soc.
  • 2005 Sep;9(3):239-242.
Nowadays, the increasing use of antibiotics induces many complications including pseudomembranous colitis. Isolates of toxigenic Clostridium difficile, the most frequent cause of antibiotic-associated pseudomembranous colitis, are almost always highly susceptible...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rifampicin-Associated Pseudomembranous Colitis

Kim HK, Kim JW, Shin OR, Cho YS, Son SH, Kim SS, Chae HS, Kim KH, Choi KY, Chung IS

  • KMID: 1929832
  • Korean J Gastrointest Endosc.
  • 2005 Jun;30(6):330-335.
Pseudomembranous colitis is a rare disease and is caused by abnormal overgrowth of toxin producing Clostridium difficile colonizing the large bowel of patients undergoing antibiotic therapy. Rifampicin is one of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rifampicin associated Pseudomembranous Colitis

Kim JH, Park JH

  • KMID: 772653
  • Korean J Gastroenterol.
  • 2004 Jun;43(6):376-379.
Pseudomembranous colitis is a dangerous but unusual side effect of antibiotics usage. We report a case of pseudomembranous colitis that developed in a 50-year-old female patient with diabetes mellitus during...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Isoniazid Induced Acute Pancreatitis

Chung BH, Nam HS, Kwon JH, Im SH, Park SH, Kim JW, Kim SJ, Lee SY, Kim YK, Park SH

  • KMID: 2318480
  • Tuberc Respir Dis.
  • 2004 Apr;56(4):411-414.
Isoniazid is a first-line drug in the treatment of tuberculosis. A variety of adverse reactions of isoniazid have been reported. These include hepatitis, peripheral neuropathy, skin rashes, neurologic disturbances and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Local Rifampicin Instillation Therapy for Suppurative Bacillus Calmette-Guerin Lymphadenitis

Kim MJ, Jang SH, Ahn YM, Kang MK, Kim SJ

  • KMID: 2335614
  • J Korean Pediatr Soc.
  • 2002 Apr;45(4):454-458.
PURPOSE: Bacillus Calmette-Guerin(BCG) lymphadenitis is one of the most common complications of BCG vaccination. The involved lymph nodes usually subside spontaneously, but they may become enlarged and form an abscess....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Usefulness of the Line Probe Assay for Rapid Detection of Rifampicin-resistant Tuberculosis

Hong SB, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS

BACKGROUND: RpoB gene mutations have been found in about 96-98% of rifampicin (RMP)-resistant Mycobacterium tuberculosis. Recent reports confirm that the in laboratory settings a rpoB gene mutation can be used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rifampicin Induced Pseudomembranous Colitis

yun JW, Hwang JH, Ham HS, Lee HC, Roh GH, Kang SJ, Suh GY, Kim HJ, Chung MP, Kwon OJ, Rhee CH, Son HC

Pseudomembranous colitis, although uncommon, is an important complication of antibiotics that is related to a variety of deleterious effects on the gastrointestinal tract. Rifampicin is one of the 1st line...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr